Search research articles
Contact Us
Filters
Showing results (71-80 of 218) with videos related to
Page
of 22
Sort By:
Biochemical and Biophysical Research Communications
|
August 2, 2005
Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs
Zhenlin Hu, Xiao Yi Yang, Yunbo Liu, et al.
Breast Cancer Research and Treatment
|
May 12, 2011
ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells
Katherine M Aird, Jennifer L Allensworth, Ines Batinic-Haberle, et al.
Immunologic Research
|
December 8, 2010
Polyclonal immune responses to antigens associated with cancer signaling pathways and new strategies to enhance cancer vaccines
Timothy M Clay, Takuya Osada, Zachary C Hartman, et al.
Clinical Breast Cancer
|
March 7, 2003
HER2 dendritic cell vaccines
Michael A Morse, Timothy M Clay, Kirsten Colling, et al.
Health Services Research
|
September 3, 2008
Improving health care efficiency and quality using tablet personal computers to collect research-quality, patient-reported data
Amy P Abernethy, James E Herndon, Jane L Wheeler, et al.
Breast Cancer Research : BCR
|
April 19, 2012
Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer
Qing Cheng, Jeffrey T Chang, Joseph Geradts, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 26, 2016
Preclinical Evaluation of 18F-Labeled Anti-HER2 Nanobody Conjugates for Imaging HER2 Receptor Expression by Immuno-PET
Ganesan Vaidyanathan, Darryl McDougald, Jaeyeon Choi, et al.
Blood
|
June 4, 2008
Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines
Michael A Morse, Amy C Hobeika, Takuya Osada, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 1, 2014
Improved tumor targeting of anti-HER2 nanobody through N-succinimidyl 4-guanidinomethyl-3-iodobenzoate radiolabeling
Marek Pruszynski, Eftychia Koumarianou, Ganesan Vaidyanathan, et al.
Bioorganic & Medicinal Chemistry
|
February 25, 2017
Benzimidazole inhibitors from the Niclosamide chemotype inhibit Wnt/β-catenin signaling with selectivity over effects on ATP homeostasis
Robert A Mook, Xiu-Rong Ren, Jiangbo Wang, et al.
Page
of 22
Search research articles
Search
Showing results (71-80 of 218) with videos related to
Sort By:
Page
of 22
Biochemical and Biophysical Research Communications
|
August 2, 2005
Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs
Zhenlin Hu, Xiao Yi Yang, Yunbo Liu, et al.
Breast Cancer Research and Treatment
|
May 12, 2011
ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells
Katherine M Aird, Jennifer L Allensworth, Ines Batinic-Haberle, et al.
Immunologic Research
|
December 8, 2010
Polyclonal immune responses to antigens associated with cancer signaling pathways and new strategies to enhance cancer vaccines
Timothy M Clay, Takuya Osada, Zachary C Hartman, et al.
Clinical Breast Cancer
|
March 7, 2003
HER2 dendritic cell vaccines
Michael A Morse, Timothy M Clay, Kirsten Colling, et al.
Health Services Research
|
September 3, 2008
Improving health care efficiency and quality using tablet personal computers to collect research-quality, patient-reported data
Amy P Abernethy, James E Herndon, Jane L Wheeler, et al.
Breast Cancer Research : BCR
|
April 19, 2012
Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer
Qing Cheng, Jeffrey T Chang, Joseph Geradts, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 26, 2016
Preclinical Evaluation of 18F-Labeled Anti-HER2 Nanobody Conjugates for Imaging HER2 Receptor Expression by Immuno-PET
Ganesan Vaidyanathan, Darryl McDougald, Jaeyeon Choi, et al.
Blood
|
June 4, 2008
Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines
Michael A Morse, Amy C Hobeika, Takuya Osada, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 1, 2014
Improved tumor targeting of anti-HER2 nanobody through N-succinimidyl 4-guanidinomethyl-3-iodobenzoate radiolabeling
Marek Pruszynski, Eftychia Koumarianou, Ganesan Vaidyanathan, et al.
Bioorganic & Medicinal Chemistry
|
February 25, 2017
Benzimidazole inhibitors from the Niclosamide chemotype inhibit Wnt/β-catenin signaling with selectivity over effects on ATP homeostasis
Robert A Mook, Xiu-Rong Ren, Jiangbo Wang, et al.
Page
of 22